MedTrace Logo

Hernia Reduction Prior to Scheduled TIF Completion

NCT03280121 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2021-02-10

Study results available
· View outcomes & findings →

Summary

Hernia Reduction Prior to Scheduled TIF Completion using EsophyX ZR transoral device

Conditions

  • Fundoplication

Interventions

DEVICE

EsophyX ZR transoral device

TIF

Sponsors & Collaborators

  • EndoGastric Solutions

    lead INDUSTRY

Principal Investigators

  • Michael Murray, MD,FACS · Northern Nevada Medical Group

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
72 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-05
Primary Completion
2020-04-30
Completion
2020-10-26
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03280121 on ClinicalTrials.gov